EJHF Editor-in-Chief
@EJHFEiC
#EJHF Editor-in-Chief X account. Posts by Professor Michael Böhm and his team. #HFA_ESC #HeartFailure #HF
Early diagnostic pathways, and holistic cardio-oncology management approach are warranted for prevention of cancer therapy-related cardiac dysfunction and HF in cancer patients and survivors onlinelibrary.wiley.com/doi/10.1002/ej… #CardioOncology @ARakisheva @EJHFEiC @ESC_Journals #EJHF
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of #HFA onlinelibrary.wiley.com/doi/10.1002/ej… @ARakisheva #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of #HFA onlinelibrary.wiley.com/doi/10.1002/ej… @ARakisheva #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_


🔥 #EVALUATE_AHF #ARNI vs #ACEi caused change in cardiac structure & function associated with improved #QoL in #HFrEF 💡A strict link between reverse remodeling & #QoL in #HF 🤝 🫀 #HFUA @MicheleEmdin @AndrewJSauer @DrMarthaGulati @JBauersachsMD bit.ly/4m6dEzc
🗞️Changes in cardiac structure & function are associated with health-related quality of life in heart failure patients with reduced ejection fraction: Results from the #EVALUATE_HF trial @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/4m6dEzc
🗞️Changes in cardiac structure & function are associated with health-related quality of life in heart failure patients with reduced ejection fraction: Results from the #EVALUATE_HF trial @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/4m6dEzc


Cardio-microcurrent device treatment for #HFpEF : Results from the C-MIC II open-label randomized controlled trial onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF @ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

🔥 #ADHF_ED Medication adherence in #ADHF : a cross sectional study in the Emergency Department 🚨 Adherence after #AHF is still poor & a major contributor to #WorseningHF, #HHF & poor outcome @MicheleEmdin @AndrewJSauer @DrMarthaGulati @JBauersachsMD bit.ly/4nO19ts
🗞️ Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency department (ADHF-ED) @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCar bit.ly/4nO19ts
🗞️ Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency department (ADHF-ED) @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCar bit.ly/4nO19ts


🚨 ~1/3 of #HF patients need rapid re-escalation after loop diuretic down-titration—linked to higher 🏥 & ☠️ Current GL advice lacks strong evidence. Time to rethink & rigorously study this common practice. ow.ly/cgp850WmZPZ @AmrAbdin10 @GiuseppeGalati_ @EJHFEiC #EJHF
In the Dutch #PREVEND cohort (n=8,338; 50% women), 796 new HF cases occurred over 156,239 person-years (median 23.4 yrs): - 533 HFrEF - 263 HFpEF 📌Doubling of urinary albumin excretion (UAE) increased HF risk: ➡️ #HFpEF: HR 1.21 (95% CI 1.13–1.30) ➡️ #HFrEF: HR 1.06 (95% CI…
Serially measured urinary albumin excretion is strongly associated with incident heart failure with preserved ejection fraction onlinelibrary.wiley.com/doi/10.1002/ej… @ESC_Journals #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
Exploring safety of down-titrating #diuretics in heart failure management : Post-hoc analysis of #TIME-CHF (n=622): Avg age: 77y | 59% male | 76% #NYHA III/IV 30-day outcomes after loop diuretic down-titration: 🔺30.4% needed re-up 🏥 Hospitalization: 3.4% ⚰️ Death: 2.0%…
Serially measured urinary albumin excretion is strongly associated with incident heart failure with preserved ejection fraction onlinelibrary.wiley.com/doi/10.1002/ej… @ESC_Journals #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_

🔥 Residual #PulmonaryHypertension & Clinical outcome in #AHF across #LVEF 🚨 Presence of #PH predicts #All_cause ☠️ & #HHF 🏥 irrespective of #LVEF No difference #HFrEF #HFmrEF #HFpEF #HFUA 🫀🍀 @ESC_Journals @EJHFEiC @MicheleEmdin @AndrewJSauer bit.ly/44ioOLd
🗞️ Residual pulmonary hypertension & clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCar bit.ly/44ioOLd
🗞️ Residual pulmonary hypertension & clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCar bit.ly/44ioOLd


Acute dyspnoea in cancer patients: secondary analysis within the Basics in Acute Shortness of breath EvaLuation (#BASEL V) study 📍 In 2,153 ED patients with acute dyspnoea, 22% had cancer. 📍 AHF was the top diagnosis in both groups (44.4% cancer vs. 51.0% non-cancer,…
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF @ESC_Journals @HanCardiomd @GiuseppeGalati_ @AmrAbdin10
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides onlinelibrary.wiley.com/doi/10.1002/ej… #EJHF @ESC_Journals @HanCardiomd @GiuseppeGalati_ @AmrAbdin10


🔥 Prognostic value of #NT_proBNP in pts with primary #MitralRegurgitation undergoing transcatheter edge-to-edge repair 📎 NT_proBNP stronger than #MIDA score in predicting #HHF & All-cause ☠️ #HFUA 🫀 🍀 @EJHFEiC @AndrewJSauer @MicheleEmdin @BiykemB bit.ly/4nrHOhJ
🗞️ Prognostic value of #NT_proBNP in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/4nrHOhJ
🗞️ Prognostic value of #NT_proBNP in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd bit.ly/4nrHOhJ


📊 The European HF Survey, a key HFA/ESC initiative, reveals critical insights into HF care across Europe—resources, reimbursement, and organizational activities. ow.ly/vFus50WgPHH @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd #EJHF
A scientific statement of the #HFA of @escardio discusses how to move our field towards the development of more effective heart failure drugs onlinelibrary.wiley.com/doi/10.1002/ej… @rudolf_deboer @HanCardiomd @AmrAbdin10 @GiuseppeGalati_


🔥🔥🔥 #ESCPrev2025 Satellite symposium on “Novel Therapies for Managing Patients with #CardioKidneyMetabolic syndrome & #HeartFailure” Together with @RInciardi & @cristina_gavina is now available for your view on @PACEcme Do not miss it! : bit.ly/3GfTT8Q @escardio